Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20033888HPVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS20043253HPVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS20044075HPVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS20049578HPVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS20043807HPVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS44033251HTLV-1ENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS44031183HTLV-1ENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS44032568HTLV-1ENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS44026682HTLV-1ENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS44026683HTLV-1ENSG00000168959.15protein_codingGRM5NoNo2915P41594
TCGA Plot Options
Drug Information
GeneGRM5
DrugBank IDDB06201
Drug NameRufinamide
Target IDBE0001192
UniProt IDP41594
Regulation Typeinhibitor
PubMed IDs21351809
CitationsWier HA, Cerna A, So TY: Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview. Paediatr Drugs. 2011 Apr 1;13(2):97-106. doi: 10.2165/11586920-000000000-00000.
GroupsApproved
Direct Classification2-heteroaryl carboxamides
SMILESNC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1
Pathways
PharmGKBPA166131606
ChEMBLCHEMBL1201754